PEPFAR on Wednesday “announced awards for a $60 million initiative, with potential for additional funding in year three, to support implementation science research and the evaluation of programs established under PEPFAR,” according to a U.S. State Department media note. “These evaluations, funded through collaboration with the Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH), and the U.S. Agency for International Development (USAID), will contribute to the evidence base for HIV programs and maximize the impact of its investments in programs around the world. Data gathered will help partner countries to strengthen their efforts to prevent new HIV infections and save lives,” the media note states, adding, “More than 35 evaluations in over 12 countries will be funded in 2012” (8/1).
“PrePex, a bloodless circumcision device for adults, will be tested in at least nine African countries in the next year, according to the backers of the tests,” the New York Times reports. PEPFAR “will pay for PrePex circumcisions for about 2,500 men in Lesotho, Malawi, South Africa, Tanzania and Uganda, said Dr. Jason B. Reed, a technical adviser to the plan,” the newspaper writes. “The Bill & Melinda Gates Foundation will pay for similar studies in Kenya, Mozambique, South Africa, Zambia and Zimbabwe,” it adds. According to the New York Times, the device “was approved by the Food and Drug Administration in January, and World Health Organization approval is expected soon.” The newspaper notes, “No surgeon is needed for the procedure; a two-nurse team slides a grooved ring inside the foreskin and guides a rubber band to compress the foreskin in the groove,” and adds, “After a week, the dead foreskin falls off like the stump of a baby’s umbilical cord or can be painlessly clipped off, said Tzameret Fuerst, chief executive of PrePex” (McNeil, 8/13).
In this post in Huffington Post’s “Impact” blog, Deborah Derrick, president of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, examines “the success of U.S. efforts to promote better global health through support for [PEPFAR] and the Global Fund to Fight AIDS, Tuberculosis and Malaria.” She highlights U.S. Secretary of State Hillary Clinton’s recent trip to Africa, writing that Clinton’s “encouraging words” at the Reach Out Mbuya health center in Uganda reinforced U.S. commitment to an AIDS-free generation. She notes both PEPFAR and the Global Fund have supported the center and adds that “through hundreds of similar local programs all over the world, the Global Fund provides treatment to 3.6 million people who are HIV-positive.”
In this post in Huffington Post’s “Healthy Living” blog, John-Manuel Andriote, a journalist and author living with HIV, writes, “For all of us living with HIV infection — Oct. 27 will mark seven years since my own diagnosis — the question we face daily, hopefully more consciously and deliberately than most, is how shall we live, knowing as we do that we will most assuredly die one day?” Reflecting on the XIX International AIDS Conference (AIDS 2012) that took place in Washington last month, he continues, “An AIDS-free generation is certainly a worthy goal,” but “even if tens of billions of additional dollars are allocated to address HIV/AIDS, even if the Republicans don’t succeed in inflicting their Darwinian ‘survival of the fittest’ upon the nation and the world, the question will continue to be what it has been for 31 years … Will we have the political will to end AIDS?”
The Centers for Disease Control and Prevention (CDC) has developed a new HIV test, called the Limiting Antigen Avidity Enzyme Immunoassay, that can tell whether a person contracted the virus within the last 141 days, “hugely important information for researchers, who need to know whether fewer people are becoming newly infected with HIV to determine whether a prevention program is working,” the Wall Street Journal’s “Health Blog” reports. Speaking last month at the XIX International AIDS Conference (AIDS 2012) in Washington, D.C., “Secretary of Health and Human Services Kathleen Sebelius called the new test ‘a major development that will help us better evaluate and improve our prevention efforts,'” the blog notes.
“U.S. Secretary of State Hillary Clinton said during a visit to South Africa that Pretoria will begin taking more of the responsibilities for its HIV/AIDS program, part of a broader effort to overhaul the U.S. global plan for AIDS relief launched under former President George W. Bush,” Reuters reports. “On Wednesday, Clinton is expected to sign a deal to rework South Africa’s programs under [PEPFAR], allowing the government to better use the funding in its fight against the virus,” the news service writes.
“Construction has begun on Ethiopia’s National Public Health Training Center, the first of its kind to be established in the country at a cost of $4 million,” Malaysian News Agency Bernama reports, noting, “The U.S. President’s Emergency Fund for AIDS Relief (PEPFAR) committed to the cost of the project, while the Atlanta-based Centers for Disease Control (CDC) will manage the construction of the ground and three facilities which are expected to be completed by April 2014” (10/23). “It will be the first national training center for health, according to the press statement from the United States Embassy in Ethiopia,” according to New Business Ethiopia, which adds, “The new national public health training center will be a state-of-the-art facility that will act as a training and support hub for Ethiopia’s national public health monitoring, research, and laboratory network” (10/23).
In this Foreign Affairs opinion piece, Todd Moss, vice president and senior fellow at the Center for Global Development and former deputy assistant secretary in the Bureau of African Affairs at the State Department, reflects on President Obama’s approach to Africa, discussing various policies by the current and previous administrations. Moss compares Obama’s approach to Africa with that of his predecessors, highlighting former President Bill Clinton’s African Growth and Opportunity Act, “which reduced trade barriers on more than 1,800 products exported from the continent to the United States,” and former President George W. Bush’s launching of the Millennium Challenge Corporation, the President’s Malaria Initiative, and the President’s Emergency Plan for AIDS Relief.
The PEPFAR scientific advisory board met this week to discuss implementation science; reaching key populations, such as drug users and men who have sex with men; and coordinating HIV testing, prevention, treatment and care efforts, the Center for Global Health Policy’s “Science Speaks” blog reports. “When [efficiency, impact, and the relevance of targets] are weighed against intentions and costs, the discipline at work is called ‘implementation science,’ and that is the science, PEPFAR leadership is hoping, that will bring the possibilities of biomedical advances and commitment to fruition,” the blog writes. U.S. Global AIDS Coordinator Ambassador Eric Goosby discussed the disconnect between the people planning HIV/AIDS services and those for whom services are intended, according to the blog (Barton, 10/4).
The Lancet examines the history of the Obama administration’s attempt to “reform the way the country delivers development assistance for health abroad” by establishing the Global Health Initiative (GHI). “Despite unusual bipartisan support in Congress and broad consensus among development practitioners about the goals of reform, it proved surprisingly difficult for the multiple entities involved in U.S. global health assistance to agree on a way forward,” the journal states, noting that GHI leadership and the three core entities of GHI — USAID, the Centers for Disease Control and Prevention (CDC) and PEPFAR — announced the closure of the GHI office and an end to the initiative’s current phase on July 3. The Lancet outlines several challenges the initiative faced, including collaboration among the three agencies, leadership, and external factors, such as “the austere budgetary climate.”